Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Latin America, Europe, the Middle East, Africa, and the...
8 insider purchases on record · latest filing 2019-09-11.
Insiders have also filed 477 sale transactions at RARE.